Edition:
United States

People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.39USD
26 Jul 2016
Change (% chg)

$-0.03 (-0.36%)
Prev Close
$8.42
Open
$8.41
Day's High
$8.55
Day's Low
$8.37
Volume
852,125
Avg. Vol
1,424,810
52-wk High
$10.95
52-wk Low
$5.57

Truitt, Joseph 

Mr. Joseph Truitt is Executive Vice President, Chief Commercial Officer of the Company. Prior to joining Achillion in January 2009, Mr. Truitt was Vice President of Business Development and Product Strategy for Lev Pharmaceuticals, Inc., a biotechnology company, from October 2007 to December 2008. From July 2006 through September 2007, he served as Lev’s Vice President of Sales and Marketing and led the build out of the commercial team and infrastructure in preparation for product launch. From February 2002 to July 2006, Mr. Truitt was Vice President of Sales and Operations at Johnson & Johnson, a pharmaceutical company, where he directed commercial operations at the company’s OraPharma subsidiary. From 2000 to 2002, Mr. Truitt was Vice President of Sales and Operations of OraPharma, Inc., a pharmaceutical company, prior to its acquisition by Johnson & Johnson. Mr. Truitt holds an M.B.A. from St. Joseph’s University, Philadelphia and a B.S. in Marketing from LaSalle University, Philadelphia.

Basic Compensation

Total Annual Compensation, USD 488,294
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,251,750
Fiscal Year Total, USD 1,740,040

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 100,000 685,209.00